Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II doxycycline study in MALT lymphoma of the ocular adnexae
2006-005795-41Phase 2Completed
- Sponsor
- International Extranodal Lymphoma Study Group
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxycycline in ocular adnexal marginal zone B cell lymphoma (OAMZL), sponsored by International Extranodal Lymphoma Study Group. Primary endpoints: Primary: Response rate to doxycycline and Primary: Duration of response to doxycycline. Started Jun 2007; status: completed.
02
Drugs
doxycycline
03
Conditions
ocular adnexal marginal zone B cell lymphoma (OAMZL)
Beyond the preview
Go deeper on 2006-005795-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005795-41.